ChemicalBook >
Produktkatalog >
Aktive pharmazeutische Wirkstoffe (APIs) >
Antineoplastische Mittel >
Antibiotika für Krebsbehandlung >1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]-
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]-
CAS-Nr.
75443-99-1
Bezeichnung:
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]-
Englisch Name:
ACLARUBICIN HYDROCHLORIDE
Synonyma:
aclacinon;Aclarubicin HCl;Aclarubicin hydrochlride;ACLARUBICIN HYDROCHLORIDE;aclacinomycinahydrochloride;ACLARUBICIN HYDROCHLORIDE USP/EP/BP;Aclarubicin hydrochloride (Aclacinomycin A);syl)oxy)-2,5,7-trihydroxy-,methylester,hydrochloride,(1r-(1-alpha,2-beta,4;n-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyrano;1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-l-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-l-lyxo
CBNumber:
CB2189954
Summenformel:
C42H54ClNO15
Molgewicht:
848.33
MOL-Datei:
75443-99-1.mol
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]- Eigenschaften
Schmelzpunkt:
151-153℃
Siedepunkt:
898℃
Flammpunkt:
>110°(230°F)
storage temp.
2-8°C
L?slichkeit
Soluble in DMSO or DMF at 25mg/ml
Aggregatzustand
Solid
Farbe
Light yellow to yellow
Sicherheit
Risiko- und Sicherheitserkl?rung
Gefahreninformationscode (GHS)
Kennzeichnung gef?hrlicher
T
R-S?tze:
23/24/25
S-S?tze:
36/37/39-45
RIDADR
3249
RTECS-Nr.
QI9283500
HazardClass
6.1(a)
PackingGroup
II
Bildanzeige (GHS)
Alarmwort
Gefahrenhinweise
Code
Gefahrenhinweise
Gefahrenklasse
Abteilung
Alarmwort
Symbol
P-Code
H301
Giftig bei Verschlucken.
Akute Toxizit?t oral
Kategorie 3
Achtung
src="/GHS06.jpg" width="20" height="20" />
P264, P270, P301+P310, P321, P330,P405, P501
H311
Giftig bei Hautkontakt.
Akute Toxizit?t dermal
Kategorie 3
Achtung
src="/GHS06.jpg" width="20" height="20" />
P280, P302+P352, P312, P322, P361,P363, P405, P501
H331
Giftig bei Einatmen.
Akute Toxizit?t inhalativ
Kategorie 3
Achtung
src="/GHS06.jpg" width="20" height="20" />
P261, P271, P304+P340, P311, P321,P403+P233, P405, P501
Sicherheit
P261
Einatmen von Staub vermeiden.
P304+P340
BEI EINATMEN: Die Person an die frische Luft bringen und für ungehinderte Atmung sorgen.
P405
Unter Verschluss aufbewahren.
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]- Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R23/24/25:Giftig beim Einatmen, Verschlucken und Berührung mit der Haut.
S-S?tze Betriebsanweisung:
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn m?glich, dieses Etikett vorzeigen).
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 41)Lieferanten
CHINA 29
Japan 1
Switzerland 1
United Kingdom 1
United States 8
USA 1
Global 41
75443-99-1(1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]-)Verwandte Suche:
3-(2-Methoxyethoxy)propylamin
2-Pentylanthrachinon
3-Benzoylphenylessigsure
Methylsalicylat
1-Naphthacencarbonsure, 2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, Methylester, Hydrochlorid, [1R-(1α,2β,4β)]-
m-Tolylessigsure
2-Hydroxy-5-methylbenzophenon
Aclarubicin
Methyl-p-tolylacetat
aclacinomycinahydrochloride
aclacinon
n-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyrano
syl)oxy)-2,5,7-trihydroxy-,methylester,hydrochloride,(1r-(1-alpha,2-beta,4
1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-l-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-l-lyxo
ACLARUBICIN HYDROCHLORIDE
1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, meth
1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride, [1R-(1α,2β,4β)]-
Aclarubicin hydrochlride
Aclarubicin HCl
Aclarubicin hydrochloride (Aclacinomycin A)
ACLARUBICIN HYDROCHLORIDE USP/EP/BP
methyl(1R,2R,4S)-4-[(2R,4S,5S,6S)-4-(dimethylamino)-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate,hydrochloride
75443-99-1
C42H54ClNO15
C42H53NO15HCl
API